{"created":"2023-05-15T14:49:31.746868+00:00","id":67819,"links":{},"metadata":{"_buckets":{"deposit":"e1e0af59-3c54-4a85-ac38-f0dc1a61f698"},"_deposit":{"created_by":1,"id":"67819","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"67819"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00067819","sets":["10:28"]},"author_link":["666377","666378"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2004-06-23","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"第５１回米国核医学会年会に参加してポスター発表（演題：NR2B/NMDA受容体の新規PETリガンドとしての炭素−１１標識シンナミジンのインビトロ及びインビボ評価）を行った。\n　今回の年会では、興奮性グルタミン酸受容体のPETリガンドに関して我々を含めて３件の報告があった。内、代謝性グルタミン酸受容体のPETリガンドの合成と評価の報告では、ラットでのインビボ特異結合が報告されインビボイメージング剤としての可能性が指摘され興味が持たれた。\n　癌のイメージングに関しては、血管新生でαVβ3インテグリンのリガンド、ヒポキシアではCu-ATSM及びFMISOの有用性評価、アポトーシスのイメージングのためのAnnexinV関連の報告が多く、臨床利用へむけての有用性が指摘されていた。","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"The Society of Nuclear Medicine advancing molecular imagimg","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Haradahira, Terushi"}],"nameIdentifiers":[{"nameIdentifier":"666377","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"原田平 輝志","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"666378","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"In vitro and vivo evaluation of C-11 labeled cinnamamidine as a new PET radioligand for NR2B/NMDA Receptors.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"In vitro and vivo evaluation of C-11 labeled cinnamamidine as a new PET radioligand for NR2B/NMDA Receptors."}]},"item_type_id":"10005","owner":"1","path":["28"],"pubdate":{"attribute_name":"公開日","attribute_value":"2004-06-28"},"publish_date":"2004-06-28","publish_status":"0","recid":"67819","relation_version_is_last":true,"title":["In vitro and vivo evaluation of C-11 labeled cinnamamidine as a new PET radioligand for NR2B/NMDA Receptors."],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T20:33:21.679274+00:00"}